A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/02/2006	US20060246076 Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2
11/02/2006	US20060246075 At least one variable region comprising at least one heavy chain and at least one light chain of selected amino acid sequences; vectors, host cells, transgenic animals or plants, diagnosis; Alzheimer's Disease
11/02/2006	US20060246074 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1- antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds
11/02/2006	US20060246073 Anti-TNF antibodies and peptides of human tumor necrosis factor
11/02/2006	US20060246072 Methods of facilitating cell survival using neurotrophin mimetics
11/02/2006	US20060246071 Blood vessel specific immunoglobulins for use in prevention and treatment of cell proliferative disorders
11/02/2006	US20060246070 Methods and compositions for treating renal cell carcinoma related pathologies
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246068 Polypeptides having a triggering NK activity and biological applications
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246063 Method for detecting regulatory T cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition
11/02/2006	US20060246062 Anti-ccr4 antibodies and methods of use therefor
11/02/2006	US20060246061 Method for generating monoclonal antibodies
11/02/2006	US20060246060 Novel stable formulation
11/02/2006	US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility
11/02/2006	US20060246058 Single-domain antigen-binding antibody fragments derived from llama antibodies
11/02/2006	US20060246057 Treatment or prevention of damage due to radiation exposure
11/02/2006	US20060246056 Immunotherapy of rectal cancer
11/02/2006	US20060246050 Catheter Composition and Uses Thereof
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246036 Delivery of therapeutics to the brain and spinal cord
11/02/2006	US20060246032 Chimeric IL-10
11/02/2006	US20060246015 Compositions and methods for the maintenance of oral health
11/02/2006	US20060246004 Antibody variants and uses thereof
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717250A1 Monoclonal antibody and use thereof
11/02/2006	EP1717248A1 Tumor targeted vector
11/02/2006	EP1717245A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	EP1716866A1 Proteoliposomes and derivatives thereof as cytotoxic response-inducing adjuvants and resulting formulations
11/02/2006	EP1716863A1 T cell immune response inhibitor
11/02/2006	EP1716416A1 Modulators of angiogenesis and tumorigenesis
11/02/2006	EP1716234A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals
11/02/2006	EP1716179A2 Monoclonal antibodies that specifically bind to folate receptor alpha
11/02/2006	EP1716178A1 Less immunogenic binding molecules
11/02/2006	EP1716174A2 Leucine rich repeat containing protein
11/02/2006	EP1716173A2 Carcinoembryonic antigen fusion protein and uses thereof
11/02/2006	EP1716171A1 IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM
11/02/2006	EP1716169A1 Ornithobacterium rhinotracheale subunit vaccines
11/02/2006	EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006	EP1715891A2 Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies
11/02/2006	EP1715890A1 Ctgf as target for the therapy of diabetic nephropathy
11/02/2006	EP1715889A2 Regulatory t cells suppress autoimmunity
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1017822B1 Lkta deletion mutant of p. haemolytica
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	EP0973534B1 Plant extracts having appetite suppressant activity
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	DE102005019845A1 New human antibody capable of human CD152 (CTLA-4) binding or an antibody fragment, useful for diagnosing or treating human diseases caused by over- and/or under-expression of CD152
11/02/2006	CA2763805A1 P-cadherin antibodies
11/02/2006	CA2609927A1 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	CA2607475A1 Method for treating dementia or alzheimer's disease with a cd20 antibody
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606429A1 Materials and methods for respiratory disease control in canines
11/02/2006	CA2606229A1 Lawsonia intracellularis immunological proteins
11/02/2006	CA2606222A1 Reagents that bind ccx-ckr2
11/02/2006	CA2606206A1 Vaccine
11/02/2006	CA2606102A1 Modulation of antibody effector function by hinge domain engineering
11/02/2006	CA2606092A1 Vaccine
11/02/2006	CA2606088A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	CA2605924A1 Recombinant flavivirus vaccines
11/02/2006	CA2605808A1 Immunostimulatory compositions
11/02/2006	CA2605749A1 Compositions and methods for cancer immunotherapy
11/02/2006	CA2604786A1 Single-chain antibody with cleavable linker
11/02/2006	CA2604225A1 Surface-modified microparticles and methods of forming and using the same
11/01/2006	CN1856575A DNA transfection system for the generation of infectious influenza virus
11/01/2006	CN1856508A Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity
11/01/2006	CN1856507A Method of stabilizing antibody and stabilized solution-type antibody preparation
11/01/2006	CN1856505A Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
11/01/2006	CN1856503A Peptide originating in hepatitis c virus
11/01/2006	CN1856325A Treatment of respiratory diseases with anti-IL-2 receptor antibodies
11/01/2006	CN1856324A Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
11/01/2006	CN1856323A Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
11/01/2006	CN1856322A Microsome vaccine
11/01/2006	CN1854157A Antibodies to insulin-like growth factor i receptor
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853721A Schweineseuche O-shaped synthetic peptide vaccine and preparation thereof
11/01/2006	CN1282656C HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
11/01/2006	CN1282486C Vaccine compsn. comprising at least two valences, one enhanced with adjuvant and not other
11/01/2006	CN1282485C Dendron shaped cell tumour vaccine for loading withered heat shock tumour cell, its preparation method and application
10/2006
10/31/2006	US7129340 Point mutations; recombinant vectors/molecular targets; transcription factors
10/31/2006	US7129339 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
10/31/2006	US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide
10/31/2006	US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
10/31/2006	US7129330 Multivalent antibody constructs
10/31/2006	US7129328 Liver tumor marker sequences
10/31/2006	US7129327 Polypeptide and protein derivatives and process for their preparation
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129223 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
10/31/2006	US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006	US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group
10/31/2006	US7129210 cross-linkable protein in the form of a solution or suspension; cross-linking agent solution includes an aldehyde and an amino acid containing species reactive with the aldehyde
10/31/2006	US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
10/31/2006	US7129060 Export systems for recombinant proteins

1 ... 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 ... 1823